fluorouracil and silybin

fluorouracil has been researched along with silybin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, HR; Chen, PN; Chu, SC; Hsieh, YS; Hung, TW; Lian, JD; Sun, YS; Wu, SW; Yang, SF1
Chan, KT; Chan, KW; Cheung, AL; Guan, XY; Law, S; Lee, NP; Li, B; Li, J; Qin, YR; Tsao, SW; Xu, WW1
Mirza, S; Patel, S; Pathak, C; Rawal, R; Shah, K; Vaidya, F; Waghela, B1
Ayazoglu Demir, E; Demir, S; Kucuk, H; Mentese, A; Turkmen Alemdar, N1

Other Studies

5 other study(ies) available for fluorouracil and silybin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
    Molecular carcinogenesis, 2011, Volume: 50, Issue:10

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Fluorouracil; HEK293 Cells; Humans; Kidney Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred ICR; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Paclitaxel; Silybin; Silymarin; Urokinase-Type Plasminogen Activator; Xenograft Model Antitumor Assays

2011
Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
    Expert opinion on therapeutic targets, 2016, Volume: 20, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Signal Transduction; Silybin; Silymarin; Xenograft Model Antitumor Assays

2016
Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
    Scientific reports, 2018, 11-19, Volume: 8, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Colonic Neoplasms; Fluorouracil; G1 Phase; HCT116 Cells; Humans; Hyaluronan Receptors; MAP Kinase Signaling System; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Resting Phase, Cell Cycle; Silybin

2018
The therapeutic effect of silibinin against 5-fluorouracil-induced ovarian toxicity in rats.
    Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:9

    Topics: Animals; Antioxidants; Caspase 3; Fluorouracil; Oxidants; Oxidative Stress; Rats; Silybin; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2023